Elke H J Krekels

19PUBLICATIONS
40CO-AUTHORS
Haematological tumoursInfant and child healthPharmacogenomicsStatistical theoryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 01, 2026
Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies.

|Oct 14, 2025
Changes in the Fraction Metabolized in Children Younger than Four Years; When is Clearance Scaling for the Dominant Elimination Route in Adults Appropriate?

Anne van Rongen, Robbin Grijseels, Elisa A M Calvier

|Jun 17, 2025
Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning.

Ananth Kadambi, Elke H J Krekels, Antal Martinecz

|Dec 07, 2024
All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology.

Daan W van Valkengoed, Elke H J Krekels, Catherijne A J Knibbe

|Oct 28, 2024
Changes in Plasma Clearance of CYP450 Probe Drugs May Not be Specific for Altered In Vivo Enzyme Activity Under (Patho)Physiological Conditions: How to Interpret Findings of Probe Cocktail Studies.

Laura M de Jong, Marinda van de Kreeke, Mariam Ahmadi

|Nov 16, 2023
How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400-600 mg·h/L-Targeted Dosing.

Tan Zhang, Elke H J Krekels, Cornelis Smit

Pageof 4

Frequent Collaborators

8 joint publications

Catherijne A J Knibbe

5 joint publications

Roger J M Brüggemann

4 joint publications

Rob C van Wijk

3 joint publications

Cornelis Smit